feedback

Course Directors

Leonard Calabrese
Leonard Calabrese, DO

Department of Rheumatic & Immunologic Diseases
Cleveland Clinic
Cleveland, OH

M. Elaine Husni
M. Elaine Husni, MD, MPH

Assistant Professor
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director, Clinical Outcomes Research
Director, Arthritis and Musculoskeletal Treatment Center
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Adam J. Brown, MD

Fellow
Department of Rheumatologic and Immunologic Diseases
Cleveland Clinic
Cleveland, OH

Cassandra M. Calabrese, DO

Department of Internal Medicine
Cleveland Clinic
Cleveland, OH

Alexander Hannan, DO

Fellow
Department of Rheumatologic and Immunologic Diseases
Cleveland Clinic
Cleveland, OH

Alana M. Nevares, MD

Fellow
Department of Rheumatologic and Immunologic Diseases
Cleveland Clinic
Cleveland, OH

Hiromichi Tamaki, MD

Fellow
Department of Rheumatologic and Immunologic Diseases
Cleveland Clinic
Cleveland, OH

Accredited by

Cleveland Clinic Center for Continuing Education

Course Description

Learning Objectives
1. Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs).
2. Critically appraise data on genetics and personalized medicine as applied to rheumatic diseases and IMIDs.
3. Analyze recent investigations on efficacy and toxicity of biologic agents across IMIDs.
4. Detail current knowledge related to predicting outcomes in patients with rheumatoid arthritis (RA).
5. Summarize updates in diagnosis, classification, therapies, and immune-system targets in both psoriatic arthritis (PsA) and spondyloarthopathies (SpA) and describe their clinical implications.
6. Critically assess clinical data on biologic use in immune-related diseases in the areas of pulmonary disease, dermatology, metabolic bone diseases, and systemic lupus erythematosus (SLE).
7. Develop strategies to predict, prevent, and treat comorbid complications of biologic therapy including cardiovascular disease and serious infections.

Activity Details

Credit Types:CME
Credit Amount:1.00 Credits
Release Date:2017-Jul-26
Expiration Date:2019-Jul-26
Estimated Time for Completion:1 hour
Registration Required:No
Cost:Free

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.